Stocks · Healthcare · Medical - Instruments & Supplies
Envista Holdings Corp NVST
$23.46 +1.30% Close, Oct 2, 2026 · NYSE · Market cap $3.82B
High qualityInexpensive vs sectorLow risk
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $0.58, up 84.4% year over year.
- Earnings beat analyst estimates in each of the last 8 quarters (average surprise over the last four: +18.9%).
- Revenue over the last four quarters was $2.86B, up 11.9% from a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 44%
- EPS growth (TTM, YoY)Top 15%
- FCF growth (TTM, YoY)Bottom 31%
- Revenue growth, 3-year CAGRBottom 28%
- Revenue growth accelerationTop 50%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 28%
- Gross marginBottom 41%
- Operating marginTop 27%
- Cash conversion (OCF / net income)Top 10%
- Accruals (lower is better)Bottom 32%
- Net debt / EBITDA (lower is better)Bottom 47%
- Interest coverTop 14%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 22%
- Free-cash-flow yieldTop 15%
- EBITDA / enterprise valueTop 13%
- Sales / enterprise valueTop 18%
- P/E vs own 5-year history (lower is better)Bottom 28%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 42%
- 6-month returnBottom 33%
- 1-year return vs S&P 500Top 47%
- Distance from 52-week highTop 36%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 25%
- Consecutive EPS beatsTop 8%
- Share of analysts rating BuyBottom 8%
- Upside to consensus price targetBottom 29%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 9%
- Maximum drawdown, 3 yearsTop 21%
- Beta vs S&P 500 (lower is better)Top 41%
- Net debt / EBITDA (lower is better)Bottom 47%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 12.1% | 11.9% | ↓ |
| Gross margin | 54.7% | 55.5% | ↑ |
| Operating margin | 6.1% | 9.9% | ↑ |
| FCF margin | 10.1% | 8.1% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 11.9% | 12.1% | ↓ | Top 44% |
| EPS growth (TTM, YoY) | 84.4% | — | Top 15% | |
| Gross margin | 55.5% | 54.7% | ↑ | Bottom 41% |
| Operating margin | 9.9% | 6.1% | ↑ | Top 27% |
| Net margin | 3.3% | 2.1% | ↑ | — |
| Free-cash-flow margin | 8.1% | 10.1% | ↓ | — |
| Return on invested capital | 2.4% | — | Top 28% | |
| Revenue growth, 3-year CAGR | 1.9% | — | Bottom 28% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -3.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -8.6 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.32×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 13.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 5.30%
- Shareholder yield
- 5.30%
- Share count change, 1 year
- -3.4%
- Share count change, 3-year CAGR
- -2.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jul 3, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 8
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +18.9%
- Average 2-day reaction, last 8
- +1.3%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $29.11
- Target vs current price
- +24.1%
- Analysts with a rating
- 20
- Share rating Buy or Strong Buy
- 40%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +22.3% | +2.4% | +2.0% | -4.7% | — |
| May 6, 2026 | +16.1% | +3.4% | -7.3% | -14.5% | +4.3% |
| Feb 5, 2026 | +18.8% | +4.4% | +27.9% | +18.0% | +11.3% |
| Oct 29, 2025 | +18.5% | -0.4% | +0.4% | +4.9% | +19.9% |
| Jul 31, 2025 | +8.3% | -5.4% | -1.3% | +6.4% | +1.3% |
| May 1, 2025 | +20.0% | +1.6% | +4.7% | +14.8% | +29.0% |
| Feb 5, 2025 | +4.3% | +2.2% | +4.4% | -9.4% | -18.8% |
| Oct 30, 2024 | +33.3% | +2.3% | +12.3% | +17.1% | +15.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | $0.41 | $0.34 | +22.3% | $730.5M |
| May 6, 2026 | $0.36 | $0.31 | +16.1% | $705.5M |
| Feb 5, 2026 | $0.38 | $0.32 | +18.8% | $750.6M |
| Oct 29, 2025 | $0.32 | $0.27 | +18.5% | $669.9M |
| Jul 31, 2025 | $0.26 | $0.24 | +8.3% | $682.1M |
| May 1, 2025 | $0.24 | $0.20 | +20.0% | $616.9M |
| Feb 5, 2025 | $0.24 | $0.23 | +4.3% | $652.9M |
| Oct 30, 2024 | $0.12 | $0.09 | +33.3% | $601.0M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 40.4× | 30.0× | 67th | Top 22% |
| P/E (forward) | 15.3× | — | — | — |
| EV / EBITDA | 12.2× | — | — | Top 13% |
| EV / Sales | 1.50× | — | — | Top 18% |
| Free-cash-flow yield | 6.08% | — | — | Top 15% |
| Earnings yield | 2.47% | — | — | Top 22% |
P/E over the past five years
Range 21.3× – 231.8× since Jul 2, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +15.2%
- Earnings per share growth (TTM)
- +84.4%
- Change in P/E multiple
- -17.8%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -3.1%
- 200-day average slope (20 days)
- +1.6%
- Distance from 50-day average
- -11.0%
- Distance from 200-day average
- -8.6%
- RSI (14)
- 35.4
- Relative volume
- 0.76×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 29.6%
- Volatility vs own 5-year history
- 16th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.96
- Correlation with S&P 500
- 0.39
- Current drawdown from 1-year high
- -22.5%
- Maximum drawdown, 3 years
- -47.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 21, 2022 | Apr 8, 2025 | -71.0% | 765 days | Not yet recovered |
| May 7, 2021 | Oct 27, 2021 | -17.0% | 120 days | 40 days (Dec 23, 2021) |
| Feb 16, 2022 | Mar 7, 2022 | -11.5% | 12 days | 9 days (Mar 18, 2022) |
| Dec 27, 2021 | Jan 27, 2022 | -11.4% | 22 days | 10 days (Feb 10, 2022) |
| Oct 23, 2020 | Oct 28, 2020 | -11.4% | 3 days | 8 days (Nov 9, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $3.82B
- P/E (TTM)
- 40.4
- EPS, diluted (TTM)
- $0.58
- Revenue (TTM)
- $2.86B
- 52-week range
- $18.77 – $30.42
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $2.51B | $2.57B | $2.57B | $2.51B | $2.72B |
| Gross profit | $1.46B | $1.49B | $1.45B | $1.39B | $1.50B |
| Operating income | $306.2M | $319.2M | $31.5M | -$1.04B | $225.7M |
| Net income | $340.5M | $243.1M | -$100.2M | -$1.12B | $47.0M |
| EPS (diluted) | $1.48 | $1.34 | -$0.60 | -$6.50 | $0.28 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $601.0M | $652.9M | $616.9M | $682.1M | $669.9M | $750.6M | $705.5M | $730.5M |
| Net income | $8.2M | $1.2M | $18.0M | $26.4M | -$30.3M | $32.9M | $38.7M | $53.7M |
| EPS (diluted) | $0.05 | $0.01 | $0.10 | $0.16 | -$0.18 | $0.20 | $0.23 | $0.33 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $361.6M | $182.7M | $275.7M | $336.5M | $275.7M |
| Capital expenditure | -$54.7M | -$75.7M | -$58.2M | -$33.8M | -$45.3M |
| Free cash flow | $306.9M | $107.0M | $217.5M | $302.7M | $230.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $19.5M | $21.8M | $11.3M | $2.4M | -$163.8M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $1.13B
- Total assets
- $5.60B
- Total liabilities
- $2.52B
- Total debt
- $1.59B
- Net debt
- $462.4M
- Shareholders’ equity
- $3.08B
As of Jul 3, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 10,210,406
- Days to cover
- 3.97
- Change vs previous report
- -10.3%
FINRA short interest, settlement date Sep 15, 2026.